Glycogen storage disease type III other imaging findings: Difference between revisions
(Created page with "__NOTOC__ {{Glycogen storage disease type III}} {{CMG}}; {{AE}} ==Overview== There are no other imaging findings associated with [disease name]. OR [Imaging modality] may...") |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Dual energy X-ray absorptiometry]] ([[DXA]]) may be helpful in the diagnosis of low [[bone mineral density]] (BMD) in patients with glycogen storage disease type 3. | |||
[ | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
* | ===Dual Energy X-ray Absorptiometry=== | ||
*Glycogen storage disease type 3 associated with low [[bone mineral density]] (BMD) due to:<ref name="pmid18392743">{{cite journal| author=Mundy HR, Williams JE, Lee PJ, Fewtrell MS| title=Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit. | journal=J Inherit Metab Dis | year= 2008 | volume= 31 | issue= 3 | pages= 418-23 | pmid=18392743 | doi=10.1007/s10545-008-0830-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18392743 }} </ref> | |||
**Abnormal muscle physiology | |||
** | **Poor metabolic control | ||
** | **Altered nutrition affecting micronutrient | ||
**[ | *[[Dual energy X-ray absorptiometry]] is used to diagnose low [[bone mineral density]] (BMD). | ||
==References== | ==References== | ||
Revision as of 18:19, 18 December 2017
|
Glycogen storage disease type III Microchapters |
|
Differentiating Glycogen storage disease type III from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type III other imaging findings On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type III other imaging findings |
|
FDA on Glycogen storage disease type III other imaging findings |
|
CDC on Glycogen storage disease type III other imaging findings |
|
Glycogen storage disease type III other imaging findings in the news |
|
Blogs on Glycogen storage disease type III other imaging findings |
|
Risk calculators and risk factors for Glycogen storage disease type III other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of low bone mineral density (BMD) in patients with glycogen storage disease type 3.
Other Imaging Findings
Dual Energy X-ray Absorptiometry
- Glycogen storage disease type 3 associated with low bone mineral density (BMD) due to:[1]
- Abnormal muscle physiology
- Poor metabolic control
- Altered nutrition affecting micronutrient
- Dual energy X-ray absorptiometry is used to diagnose low bone mineral density (BMD).
References
- ↑ Mundy HR, Williams JE, Lee PJ, Fewtrell MS (2008). "Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit". J Inherit Metab Dis. 31 (3): 418–23. doi:10.1007/s10545-008-0830-0. PMID 18392743.